SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the ...

The University of Queensland will play a key role in a national effort to revolutionise treatment for men with prostate cancer.Radiopharmaceutical ...

Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

The latest Cut Through Ventures startup funding report shows AI deals dominated Q1 of 2025. But there's a good reason for ...

Blue-chip stocks are known for their stability and long-term growth potential, making them a favorite among investors. Our recent analysis identified 15 top blue-chip stocks, including Eli Lilly, ...

On February 10, the company announced a collaboration with AdvanCell to advance cancer treatment through targeted alpha ...

Cancer treatment start-up AdvanCell’s raised $171 million and Aravax raised $66 million to help grow its allergy symptom reduction products. The average deal size rose to an all-time high over ...

The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion dollar ...